An endothelin antagonist for resistant hypertension

被引：1
|
作者：
Dhaun, Neeraj [1 ,2 ]
Goddard, Jane [2 ]
Webb, David J. [1 ]
机构：
[1] Univ Edinburgh, Clin Pharmacol Unit, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland
[2] Royal Infirm Edinburgh NHS Trust, Dept Renal Med, Edinburgh, Midlothian, Scotland
来源：
LANCET | 2010年 / 375卷 / 9715期
关键词：
BLOOD-PRESSURE; A RECEPTOR;
D O I：
10.1016/S0140-6736(10)60259-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：635 / 635
页数：1
相关论文
共 50 条
  • [31] Resistant hypertension
    Shariati, Farnoosh
    Tandan, Nitin
    Lavie, Carl J.
    CURRENT OPINION IN CARDIOLOGY, 2024, 39 (04) : 266 - 272
  • [32] ROLE OF ENDOTHELIN IN THE DEVELOPMENT OF DAHL HYPERTENSION
    GOLIGORSKY, MS
    IIJIMA, K
    MORGAN, M
    YANAGISAWA, M
    MASAKI, T
    LIN, L
    NASJLETTI, A
    KASKEL, F
    FRAZER, M
    BADR, KF
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1991, 17 : S484 - S491
  • [33] Endothelin antagonists in hypertension and kidney disease
    Meyers, Kevin E. C.
    Sethna, Christine
    PEDIATRIC NEPHROLOGY, 2013, 28 (05) : 711 - 720
  • [34] A review of novel endothelin antagonists and overview of non-steroidal mineralocorticoid antagonists for treating resistant hypertension: An update
    Blazek, Olivia
    Bakris, George L.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 979
  • [35] Preliminary Study of the Specific Endothelin A Receptor Antagonist Zibotentan in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer
    Trump, Donald L.
    Payne, Heather
    Miller, Kurt
    de Bono, Johann S.
    Stephenson, Joe
    Burris, Howard A., III
    Nathan, Faith
    Taboada, Maria
    Morris, Thomas
    Hubner, Andreas
    PROSTATE, 2011, 71 (12): : 1264 - 1275
  • [36] Effect of an endothelin antagonist on hemodynamic responses to angiotensin II
    Balakrishnan, SM
    Wang, HD
    Gopalakrishnan, V
    Wilson, TW
    McNeill, JR
    HYPERTENSION, 1996, 28 (05) : 806 - 809
  • [37] Effects of an Endothelin Receptor Antagonist on a Model of Hypertensive Retinopathy
    McDonald, Louise
    Lee, Graham R.
    deGooyer, Tanyth E.
    McDonald, Denise
    Canning, Paul
    Kelso, Elizabeth J.
    McDermott, Barbara J.
    Stitt, Alan W.
    OPHTHALMIC RESEARCH, 2010, 43 (02) : 99 - 107
  • [38] Application of omics in hypertension and resistant hypertension
    Guo, Jiuqi
    Guo, Xiaofan
    Sun, Yingxian
    Li, Zhao
    Jia, Pengyu
    HYPERTENSION RESEARCH, 2022, 45 (05) : 775 - 788
  • [39] The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice
    Watson, A. M. D.
    Li, J.
    Schumacher, C.
    de Gasparo, M.
    Feng, B.
    Thomas, M. C.
    Allen, T. J.
    Cooper, M. E.
    Jandeleit-Dahm, K. A. M.
    DIABETOLOGIA, 2010, 53 (01) : 192 - 203
  • [40] Pharmacological Characterization of Aprocitentan, a Dual Endothelin Receptor Antagonist, Alone and in Combination with Blockers of the Renin Angiotensin System, in Two Models of Experimental Hypertension
    Trensz, Frederic
    Bortolamiol, Celine
    Kramberg, Markus
    Wanner, Daniel
    Hadana, Hakim
    Rey, Markus
    Strasser, Daniel S.
    Delahaye, Stephane
    Hess, Patrick
    Vezzali, Enrico
    Mentzel, Ulrich
    Menard, Joel
    Clozel, Martine
    Iglarz, Marc
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2019, 368 (03): : 462 - 473
12345